J Frontier Co., Ltd. (2934) AI Stock Analysis

• Market Cap: ¥9.40B
• Dividend Yield: N/A
• Average Volume (3M): 17.96K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.24
• Revenue Growth: 31.42%
• EPS Growth: 34.01%
• Country: JP
• Employees: 315
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -267.91
• Shares Outstanding: 5,220,195
• 10 Day Avg. Volume: 27,230
• 30 Day Avg. Volume: 17,956
• PEG Ratio: 0.01
• Price to Book (P/B): 4.43
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.67
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 47 Neutral
• Price Target: ¥1,702.00 ▼(-5.44%Downside)

The overall score reflects significant financial challenges, including negative profitability and cash flow issues, which are major risks. The technical analysis shows mixed signals, but the valuation is weak due to a negative P/E ratio and no dividend yield.

J Frontier Co., Ltd. Business Overview & Revenue Model

Company Description

J Frontier Co., Ltd. is a Japan-based company primarily engaged in the healthcare and beauty sectors. The company offers a range of products and services that include online medical consultations, health-related e-commerce, and other digital healthcare solutions. J Frontier Co., Ltd. leverages technology to bridge the gap between consumers and healthcare providers, facilitating access to medical and wellness products.

How the Company Makes Money

J Frontier Co., Ltd. generates revenue through multiple streams. Firstly, the company earns money from its e-commerce platform, which sells a variety of health and beauty products directly to consumers. Additionally, the company provides online medical consultation services, where it charges fees for virtual appointments and related healthcare services. The company also partners with healthcare providers and pharmaceutical companies to expand its service offerings and improve its product range. Furthermore, J Frontier Co., Ltd. may receive revenue from advertising or promotional partnerships on its platforms, contributing to its overall earnings.

J Frontier Co., Ltd. Financial Statement Overview

Summary

J Frontier Co., Ltd. has shown revenue growth, but faces significant profitability challenges with negative EBIT and EBITDA margins. The balance sheet shows higher leverage, increasing financial risk, and negative cash flows indicate operational inefficiencies.

Income Statement

The company has shown revenue growth over the years, with a notable increase from 2022 to 2023. However, the profitability metrics such as EBIT and net income have been negative in recent years, indicating operational challenges. The gross profit margin has remained fairly stable, but negative EBIT and EBITDA margins suggest significant costs impacting earnings.

Balance Sheet

The debt-to-equity ratio has increased, indicating higher leverage, which poses a risk if earnings do not improve. Although the equity ratio has decreased, the company still maintains a positive stockholder equity, suggesting some balance sheet resilience. However, the declining ROE reflects inefficiencies in generating returns from equity.

Cash Flow

The company has struggled with negative operating and free cash flows, indicating cash generation issues. The free cash flow has not shown improvement, and the operating cash flow to net income ratio is negative, highlighting challenges in converting profits into cash. While financing activities have provided some relief, reliance on external funding is not sustainable long-term.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
20.54B	17.71B	16.84B	11.88B	8.49B	7.11B
	Gross Profit
9.27B	8.33B	7.12B	5.40B	6.63B	5.49B
	EBIT
-200.67M	-553.00M	-1.82B	731.15M	671.91M	170.40M
	EBITDA
-1.08B	-1.22B	-1.54B	760.66M	706.10M	276.77M
	Net Income Common Stockholders
-1.79B	-2.09B	-1.90B	400.52M	424.93M	96.37M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.88B	1.81B	1.65B	2.96B	1.64B	908.06M
	Total Assets
9.14B	10.71B	7.24B	6.10B	2.59B	2.03B
	Total Debt
4.93B	5.17B	2.14B	546.79M	75.21M	168.86M
	Net Debt
3.05B	3.35B	487.67M	-2.41B	-1.56B	-739.20M
	Total Liabilities
7.47B	9.09B	4.53B	1.94B	1.33B	1.19B
	Stockholders Equity
1.16B	1.15B	2.48B	4.14B	1.27B	842.76M
Cash Flow		Free Cash Flow
0.00	-1.54B	-1.94B	-377.40M	823.99M	213.16M
	Operating Cash Flow
0.00	-1.44B	-1.83B	-366.94M	830.91M	218.30M
	Investing Cash Flow
0.00	-1.79B	-1.13B	-860.09M	-7.99M	-165.10M
	Financing Cash Flow
0.00	3.39B	1.45B	2.56B	-93.65M	-99.10M

J Frontier Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1800.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Positive. The current price of 1800 is above the 20-day moving average (MA) of 1627.75, above the 50-day MA of 1715.74, and above the 200-day MA of 1691.82, indicating a bullish trend. The MACD of 11.87 indicates Negative momentum. The RSI at 62.39 is Neutral, neither overbought nor oversold. The STOCH value of 83.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2934.

J Frontier Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥19.29B	17.61		2.12%	12.51%	9.68%
4483	68 Neutral	¥248.23B	34.11		0.42%	28.85%	54.60%
4320	67 Neutral	¥10.19B	21.30		2.81%	9.21%	-20.04%
3939	65 Neutral	¥19.21B	19.60		1.60%	17.20%	20.25%
Sector *	54 Neutral	$5.37B	3.26	-45.10%	3.30%	16.81%	0.02%
2934	47 Neutral	¥9.40B	―		―	31.42%	34.01%
3902	43 Neutral	¥15.36B	4,465.71		1.65%	-7.98%	-181.00%